0

Back to Immuno-Oncology: Next-Generation Sequencing and the New Biomarker Landscape
Immuno-Oncology: Next-Generation Sequencing and the New Biomarker Landscape

Immuno-Oncology: Next-Generation Sequencing and the New Biomarker Landscape

This case based, interactive online course will allow pathologists and laboratory professionals, as well as oncologists and other members of the multidisciplinary cancer care team, to gain key scientific knowledge and skills in utilizing biomarkers, particularly next-generation sequencing for identifying tumor mutation burden, for testing and selection of appropriate IO therapies, to provide patients with a personalized approach during each stage of their treatment regimens.

 

The activity offers 1.5 CME, CMLE, or SAMs CME credit.

  • List Price: $0.00 USD

Item Details:

Immuno-oncology, which engages the patient’s immune system responses to fight cancer, has revolutionized cancer treatment in the past 20 years. Although surgery, radiation, and chemotherapy remain the current standard of therapeutic approaches for cancer care, the rapidly evolving science of IO has...

Back to Immuno-Oncology: Next-Generation Sequencing and the New Biomarker Landscape
View More

Bought This Bought That ...